Humanized single domain antibodies for therapeutic brain delivery
Closed Pre-Solicitation Posted
- Solicitation number
- 75N98026Q00867
- Agency
-
Office of Logisitics and Acquisition Operations
National Institutes of Health, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- Not on record
- PSC
- 6640 Laboratory Equipment And Supplies
- Place of performance
- Bethesda, Maryland 20892, United States
- Points of contact
-
- Towanda Daniels danielt@mail.nih.gov (301) 496-9111
Notice details come from SAM.gov. Updated .
About this opportunity
The National Institutes of Health, National Heart, Lung, and Blood Institute is preparing to issue a Small Business Innovation Research Phase II solicitation for humanized single domain antibodies capable of crossing the blood-brain barrier for therapeutic brain delivery, with a pre-solicitation notice response deadline of August 3, 2026. Creative Biolabs has been identified as the anticipated offeror. No set-aside applies. The work involves development of antibodies for treating neurological conditions. Interested parties should monitor NIH solicitation channels for formal RFP release, including technical requirements, evaluation criteria, and submission deadlines. The solicitation number is 75N98026Q00867; contracting activity is the NIH Office of Logistics and Acquisition Operations.
Notice text
See attached NOI
77N98026Q00867
Files
| File | Type | Posted |
|---|---|---|
| NOI Creative Biolabs 75N98026Q00867.docx | DOCX document |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| 2027 NIAID DMID Omnibus Broad Agency Announcement: Development of Medical Interventions for Infectious Diseases | National Institute of Allergy and Infectious Diseases | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity